Bio-Gene Technology Limited (ASX:BGT)
Australia flag Australia · Delayed Price · Currency is AUD
0.0350
0.00 (0.00%)
Mar 9, 2026, 3:03 PM AEST

Bio-Gene Technology Cash Flow Statement

Millions AUD. Fiscal year is Jul - Jun.
Fiscal Year
TTM FY 2025 FY 2024 FY 2023 FY 2022 FY 2021 2020 - 2016
Period Ending
Dec '25 Jun '25 Jun '24 Jun '23 Jun '22 Jun '21 2020 - 2016
Net Income
-2.52-2.58-2.41-3.1-2.91-2.4
Upgrade
Depreciation & Amortization
0.040.040.040.050.040.05
Upgrade
Stock-Based Compensation
---0.050.450.37
Upgrade
Other Operating Activities
-0.14--0.010.040.04
Upgrade
Change in Accounts Receivable
0.030.03-0.1-0.010.09-0.04
Upgrade
Change in Accounts Payable
0.130.13-0.22-0.350.320.18
Upgrade
Change in Other Net Operating Assets
-0.16-0.16-0.060.08-0.02-0.03
Upgrade
Operating Cash Flow
-2.62-2.54-2.75-3.28-1.99-1.83
Upgrade
Capital Expenditures
---0.01--0.01-0
Upgrade
Investing Cash Flow
---0.01--0.01-0
Upgrade
Long-Term Debt Issued
-0.05----
Upgrade
Long-Term Debt Repaid
----0.08-0.08-0.01
Upgrade
Net Debt Issued (Repaid)
-0.05--0.08-0.08-0.01
Upgrade
Issuance of Common Stock
2.461.52.03-4.720.27
Upgrade
Other Financing Activities
-0.1-0.08-0.06--0.24-0.02
Upgrade
Financing Cash Flow
2.361.471.98-0.084.410.24
Upgrade
Net Cash Flow
-0.26-1.07-0.78-3.352.41-1.59
Upgrade
Free Cash Flow
-2.62-2.54-2.76-3.28-2-1.83
Upgrade
Free Cash Flow Margin
---15065.19%-2195.48%-448.66%-2920.54%
Upgrade
Free Cash Flow Per Share
-0.01-0.01-0.01-0.02-0.01-0.01
Upgrade
Cash Interest Paid
-----0
Upgrade
Cash Income Tax Paid
--0.54-0.5-0.45-0.51-0.43
Upgrade
Levered Free Cash Flow
-1.64-1.54-1.89-2.26-0.88-0.98
Upgrade
Unlevered Free Cash Flow
-1.64-1.54-1.89-2.26-0.88-0.98
Upgrade
Change in Working Capital
-0-0-0.38-0.280.390.11
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.